TipRanks
Newbury Pharmaceuticals AB (SE:NEWBRY)
:NEWBRY
Sweden Market
NEWBRY
Newbury Pharmaceuticals AB
RESEARCH TOOLSreports

Newbury Pharmaceuticals AB (NEWBRY) Income Statement

0 Followers

Newbury Pharmaceuticals AB Income Statement

Last quarter (Q2 2025), Newbury Pharmaceuticals AB's total revenue was kr12.43M, an increase of 296.62% from the same quarter last year. In Q2, Newbury Pharmaceuticals AB's net income was kr-1.85M. See Newbury Pharmaceuticals AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Aug 24Aug 23Aug 22Aug 21
Total Revenue
kr 36.83Mkr 10.27Mkr 5.52Mkr 2.83M
Gross Profit
kr 16.03Mkr 3.95Mkr 1.56Mkr 460.00K
Operating Expenses
kr 30.11Mkr 23.54Mkr 16.23Mkr 6.08M
Depreciation and Amortization
kr 1.74Mkr 1.25Mkr 1.01Mkr 608.00K
EBITDA
kr -12.14Mkr -18.33Mkr -13.66Mkr -4.91M
Operating Income
kr -14.08Mkr -19.59Mkr -14.67Mkr -5.62M
Other Income/Expenses
kr -1.33Mkr 156.00Kkr -2.29Mkr 64.00K
Pretax Income
kr -15.41Mkr -19.43Mkr -14.67Mkr -5.56M
Net Income
kr -15.40Mkr -19.43Mkr -14.67Mkr -5.56M
Per Share Metrics
Basic EPS
kr -0.72kr -1.00kr -0.75kr -0.35
Diluted EPS
kr -0.72kr -1.00kr -0.75kr -0.35
Weighted Average Shares Outstanding
 21.41M 19.52M 19.52M 15.68M
Weighted Average Shares Outstanding (Diluted)
 21.41M 19.52M 19.52M 15.68M
Currency in SEK

Newbury Pharmaceuticals AB Earnings and Revenue History